skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Heterotopic new bone formation causes resorption of the inductive bone matrix

Journal Article · · Clinical Orthopaedics and Related Research; (USA)
; ;  [1]
  1. Karolinska Institute and Hospital, Stockholm (Sweden)

The bone matrix of growing rats was labeled by multiple injections of 3H-proline, and demineralized bone matrix (DBM) was prepared. The DBM was allotransplanted heterotopically into growing rats. New bone formation was induced in and around the implants. The new bone formation was accompanied by a decrease in the content of 3H; 20 and 30 days after implantation, 72% and 46%, respectively, of the activity remained in the implants. Daily injections of indomethacin (2 mg/kg) inhibited calcium uptake by about 20% at 20 and 30 days and inhibited the release of 3H from the DBM to a similar degree. Heterotopic bone induction by DBM is accompanied by matrix resorption, and inhibition of the new bone formation decreases the resorption of DBM.

OSTI ID:
6522249
Journal Information:
Clinical Orthopaedics and Related Research; (USA), Vol. 257; ISSN 0009-921X
Country of Publication:
United States
Language:
English